News

With its collaborators Genentech, Icelandic company DeCode Genetics has found a rare gene variant that marks protection against both Alzheimer's disease and general cognitive decline. This ...
Reykjavik-based deCODE is searching for disease-gene links by analysing Iceland’s unique genetic heritage, which has remained stable since the Vikings arrived in the ninth and 10th centuries.
When people are told about risk genes in their DNA, that information is only useful if something can be done to mitigate that risk or therapies have been developed for the disorder; these are known as ...
News about deCODE Genetics, Incorporated, including commentary and archival articles published in The New York Times.
Scientists at deCODE genetics, a subsidiary of Amgen, have published a study on actionable genotypes detected in the Icelandic population and their association with lifespan. The results of ...
DeCode scientists reported yesterday that people who inherit two copies of the gene – one from each parent – are more than twice as likely to develop diabetes as those who don’t carry any copies.
In a bid to bolster its drug discovery efforts, the biotechnology giant Amgen said Monday that it would pay $415 million to acquire deCODE Genetics, a gene-hunting business known for its headline ...
News about deCODE Genetics, Incorporated, including commentary and archival articles published in The New York Times.